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Prevalence surveys for podoconiosis and other neglected 
skin diseases: time for an integrated approach
Understanding of the geographical distribution of 
diseases is needed to inform health service design 
and delivery. It is also a necessary step in targeting 
priority areas and serves as a baseline to measure the 
impact of future interventions. In The Lancet Global 
Health, Kebede Deribe and col leagues1 present a large-
scale nationwide prevalence survey for podoconiosis 
in all 30 districts across Rwanda. Podoconiosis is a 
neglected tropical disease and data on its prevalence 
and geographical distribution worldwide is scarce.2 
Podoconiosis is a type of elephantiasis (lymphoedema) 
found in farming communities in the tropics and is 
triggered by an abnormal reaction to irritant mineral parti-
cles in volcanic soils amongst people who cannot afford 
shoes. The disease can be avoided by appropriate use of 
footwear and is treated through simple lymphoedema 
management measures, such as proper foot hygiene, 
bandaging, and exercises.3 As such, detection of affected 
and at-risk populations is vital to ensure prevention and 
treatment measures are available for everyone in need.
The survey by Deribe and colleagues1 is an impressive 
and substantial undertaking that has been done at 
an almost unprecedented scale, reaching more than 
1 in 10 Rwandans. Few mapping projects for any 
disease have been done anywhere in the world at 
this scale and the authors are to be congratulated for 
managing the logistics of such a challenge. To achieve 
this feat, the researchers trained 282 community 
health workers to do a census and screen for cases of 
lymphoedema before confirmation of podoconiosis 
by a team of expert examiners. This operational model 
has previously been used for other skin diseases such as 
leprosy and Buruli ulcer.4
The study also highlights challenges involved in 
mapping a relatively rare disease. Around 1·3 million 
individuals were screened to identify 914 cases of 
podoconiosis. Although these diagnoses are an 
impressive achievement, there is also a need to reflect 
on how to establish effective ongoing case detection 
for rare conditions, which are often highly focal 
(geographically), outside of a research agenda. This 
challenge is not restricted to podoconiosis and is 
true of various other skin-related neglected tropical 
diseases, such as leprosy, yaws, Buruli ulcer, mycetoma, 
cutaneous leishmaniasis, and scabies.5 Integrated 
case finding through skin examination is one possible 
approach to identify multiple conditions in a single 
visit, and WHO has developed a manual to aid training 
of front-line health workers in recognition of the 
signs and symptoms of neglected skin diseases.6 An 
integrated approach might target not only neglected 
tropical diseases, but also common skin conditions and 
skin health in general. Studies are needed to explore if 
the model of community health worker screening and 
expert verification can be extended to multiple diseases 
and to validate diagnostic algorithms and training 
packages that can be delivered on a large scale by health 
systems. Although national programmes will need to 
be tailored to neglected tropical diseases of the skin that 
prevail in a given country, there are opportunities to 
develop common and cross-cutting tools.
Deribe and colleagues report that podoconiosis is 
widespread across Rwanda, with an overall prevalence 
of 68·5 per 100 000 people (95% CI 41·0–109·7). 
These findings add to a growing body of evidence that 
podoconiosis is a substantial public health problem. 
Progress with the mapping of this disease has been 
hampered by a scarcity of interest and investments 
in epidemiological surveys and by the inconsistent 
methodologies that have been used to assess its 
geographical distribution and spatial epidemiology.2 
In May, 2017, Deribe and colleagues7 announced in 
The Lancet Global Health the launch of a programme 
to develop a global atlas of podoconiosis through 
funding from the Wellcome Trust. They have mapped 
the distribution of the disease in Cameroon8 and are in 
the process of mapping podoconiosis in other African 
countries and India. Notably, the study provides 
guidance for the standardised design, implementation, 
analysis, and reporting of podoconiosis surveys. The 
study describes an accurate and precise methodology 
that combines several developments, including the use 
of clear case definitions, a diagnostic algorithm,8 the 
application of a grading system,9 and the adoption of 
validated modelling with environmental data to predict 
the prevalence of the disease in unsampled locations.10 
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In 2011, podoconiosis was recognised by WHO as a 
neglected condition, but the disease does not appear 
on the 2018 list of WHO neglected tropical diseases. 
Owing to similarities in the clinical presentation and 
morbidity management strategies between  lymphatic 
filariasis and podoconiosis, podoconiosis was previously 
grouped alongside the lymphatic filariasis programme. 
Despite this, podoconiosis is often found in different 
regions of countries where lymphatic filariasis is 
endemic and also in countries where lymphatic filariasis 
is not found at all (as the present study in Rwanda 
shows). Consequently, inadequate coverage of health 
interventions for people with podoconiosis is expected 
from programmes that are based only on the presence 
of lymphatic filariasis. Podoconiosis affects the poorest 
individuals, is easily preventable and treatable, and—as 
this study shows—requires a WHO programme that 
is separate from the Global programme to Eliminate 
Lymphatic Filariasis.
Michael Marks, *Oriol Mitja
Clinical Research Department, Faculty of Infectious and Tropical 
Diseases, London School of Hygiene & Tropical Medicine, London 
UK (MM); Hospital for Tropical Diseases, London, UK (MM); 
Infectious Diseases Department, Hospital Universitari Germans 
Trias i Pujol, Badalona 08916, Spain (OM); and Barcelona Institute 
for Global Health, University of Barcelona, Barcelona, Spain (OM) 
omitja@flsida.org
MM is employed by the London School of Hygiene & Tropical Medicine, where 
authors of the linked Article are also employed. The authors work in a different 
department to MM and were not involved in this work. OM declares no 
competing interests.
Copyright © 2019 The Author(s). Published by Elsevier Ltd. This is an Open 
Access article under the CC BY-NC-ND 4.0 license.
1 Deribe K, Mbituyumuremyi A, Cano J, et al. Geographical distribution and 
prevalence of podoconiosis in Rwanda: a cross-sectional country-wide 
survey. Lancet Global Health 2019; published online March 26. 
http://dx.doi.org/10.1016/S2214-109X(19)30072-5.
2 Deribe K, Cano J, Trueba ML, Newport MJ, Davey G. Global epidemiology of 
podoconiosis: a systematic review. Plos Negl Trop Dis 2018; 12: e0006324.
3 Negussie H, Molla M, Ngari M, et al. Lymphoedema management to 
prevent acute dermatolymphangioadenitis in podoconiosis in northern 
Ethiopia (GoLBeT): a pragmatic randomised controlled trial. 
Lancet Glob Health 2018; 6: e795–803.
4 Amofah G, Bonsu F, Tetteh C, et al. Buruli ulcer in Ghana: results of a 
national case search. Emerg Infect Dis 2002; 8: 167–70.
5 Mitjà O, Marks M, Bertran L, et al. Integrated control and management of 
Neglected Tropical Skin Diseases. Plos Negl Trop Dis 2017; 11: e0005136.
6 Hay R, Fuller C, Mitjà O, Yotsu R. Recognizing neglected tropical diseases 
through changes on the skin: a training guide for front-line health workers. 
Geneva: World Health Organization; 2018.
7 Deribe K, Cano J, Newport MJ, et al. The global atlas of podoconiosis. 
Lancet Glob Health 2017; 5: e477–79.
8 Deribe K, Andrew AB, Cano J, et al. Mapping the geographical distribution 
of podoconiosis in Cameroon using parasitological, serological, and clinical 
evidence to exclude other causes of lymphedema. Plos Negl Trop Dis 2017; 
12: e0006126.
9 Tekola F, Ayele Z, Mariam DH, Fuller C, Davey G. Development and testing 
of a de novo clinical staging system for podoconiosis (endemic non-filarial 
elephantiasis). Trop Med Int Health 2008; 13: 1277–83.
10 Deribe K, Cano J, Newport MJ, et al. Mapping and modelling the 
geographical distribution and environmental limits of podoconiosis in 
Ethiopia. PLoS Negl Trop Dis 2015; 9: e0003946.
